D‐penicillamine versus zinc sulfate as first‐line therapy for Wilson's disease

Abstract

DPA and ZS are effective in the majority of WD patients. Neither therapy appears to be clearly superior. Therefore ZS may be considered a reasonable alternative to DPA as a first-line therapy.